"Przychodnia specjalistyczna NZOZ All - Medicus prowadzi poradnie: - kardiologiczną - chorób zakaźnych - gastroenterologiczna - hepatologiczną - okulistyczną - ortopedyczną i gabinet fizjoterapii - zdrowia psychicznego - chirurgii urazowo - ortopedycznej - dietetyczną - logopedyczną i neurologopedyczną Wykonujemy badania: - kolonoskopia - gastroskopia - endoskopię - USG bioderek u niemowląt - EKG - echo serca - analityczne"

During the past decade, NZOZ All Medicus conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 13 clinical trials were completed, i.e. on average, 65% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 11 clinical trials were completed. i.e. 1100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NZOZ All Medicus" #1 sponsor was "Shire" with 5 trials, followed by "Celgene" with 4 trials sponsored, "Galapagos NV" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "Ferring Pharmaceuticals" with 3 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NZOZ All Medicus" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "NZOZ All Medicus" are "Ulcerative Colitis" (13 trials), "Crohn's Disease" (6 trials), "Crohn Disease" (3 trials) and "Primary Biliary Cirrhosis" (1 trials). Many other conditions were trialed in "NZOZ All Medicus" in a lesser frequency.

Most popular intervention types in "NZOZ All Medicus" are "Drug" (21 trials), "Other" (7 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Filgotinib" (4 trials), "Ontamalimab" (4 trials), "Ozanimod" (4 trials) and "Etrolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "NZOZ All Medicus" are 22 trials for "All" genders.

Currently, there are NaN active trials in "NZOZ All Medicus". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 10 completed trials in NZOZ All Medicus, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in NZOZ All Medicus, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".